DDW 2022: Investigational Liver-Targeted Therapy Proves Promising Therapeutic for Celiac Disease
Phase I trials demonstrated good safety and encouraging physiologic activity
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.